🔥🐔 BizChicken 🐔🔥

Companies Similar to Replimune Group, Inc.

Sign Up Today!

ImmunityBio, Inc.

Market Cap: High

Employees: Medium

Therapies and Vaccines

Immunity Bio, Inc. is a clinical-stage biotechnology company developing therapies and vaccines to treat cancers and infectious diseases, with a focus on immunotherapy and cell therapy platforms. The company collaborates with several institutes and has multiple therapeutic agents in clinical trials.

Tags: biotechnology, cancer, cell therapy, immunotherapy, infectious diseases, vaccines

Website

Symbol: IBRX

Recent Price: $2.68

Industry: Biotechnology

CEO: Mr. Richard Gerald Adcock

Sector: Healthcare

Employees: 622

Address: 3530 John Hopkins Court, San Diego, CA 92121

Phone: 858 633 0300

Last updated: 2024-12-31

Lyell Immunopharma, Inc.

Market Cap: Low

Employees: Low

LYL797, LYL845, NY-ESO-1

Lyell Immunopharma, Inc. is a biopharmaceutical company developing T cell therapies focused on treating patients with solid tumors using advanced genetic and epigenetic reprogramming technologies.

Tags: T cell therapy, biotechnology, cancer treatment, epigenetic reprogramming, genetic reprogramming, solid tumors

Website

Symbol: LYEL

Recent Price: $0.62

Industry: Biotechnology

CEO: Dr. Lynn Seely M.D., Ph.D.

Sector: Healthcare

Employees: 224

Address: 201 Haskins Way, South San Francisco, CA 94080

Phone: 650 695 0677

Leadership

Lynn Seely, M.D., President & Chief Executive Officer
Stephen Hill, Chief Operating Officer
Matthew Lang, J.D., Chief Business Officer
Gary Lee, Ph.D., Chief Scientific Officer
Charles Newton, Chief Financial Officer
Ellen Rose, Senior Vice President, Investor Relations and Communications
Bryan Selby, Senior Vice President, Clinical Development Operations
Ann Tomlin, Senior Vice President, Human Resources
Rick Klausner, M.D., Founder & Board Chair
Crystal Mackall, M.D., Founder
Stan Riddell, M.D., Founder
Hans Bishop, Director
Otis Brawley, M.D., Director
Catherine Friedman, Director
Elizabeth Nabel, M.D., Director
Robert Nelsen, Director
William Rieflin, Director

Last updated: 2024-12-31

INmune Bio, Inc.

Market Cap: Low

Employees: Lowest

INKmune

INmune Bio, Inc. is a clinical-stage immunotherapy company focused on developing drugs to reprogram the patient's innate immune system for the treatment of hematologic malignancies, solid tumors, chronic inflammation, and Alzheimer's disease.

Tags: Alzheimer's disease, chronic inflammation, hematologic malignancies, immunotherapy, solid tumors

Website

About | Contact | About | About | About

Symbol: INMB

Recent Price: $4.65

Industry: Biotechnology

CEO: Dr. Raymond Joseph Tesi M.D.

Sector: Healthcare

Employees: 11

Address: 225 NE Mizner Boulevard, Boca Raton, FL 33432

Phone: 858 964 3720

Last updated: 2024-12-31

Replimune Group, Inc.

Market Cap: Medium

Employees: Medium

RP1

Replimune Group, Inc. develops oncolytic immuno-gene therapies to treat cancer using its proprietary Immunotherapy platform. Its lead product, RP1, is in clinical trials for treating solid tumors.

Tags: RP1, biotechnology, cancer treatment, immunotherapy, oncolytic therapy

Website

Symbol: REPL

Recent Price: $12.33

Industry: Biotechnology

CEO: Dr. Sushil Patel Ph.D.

Sector: Healthcare

Employees: 331

Address: 500 Unicorn Park Drive, Woburn, MA 01801

Phone: 781 222 9600

Last updated: 2024-12-31

Reviva Pharmaceuticals Holdings, Inc.

Market Cap: Lowest

Employees: Lowest

RP5063

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing next-generation therapeutics for unmet medical needs, particularly in central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases.

Tags: CNS diseases, RP1208, RP5063, biopharmaceutical, clinical-stage, therapeutics

Website

Symbol: RVPH

Recent Price: $1.81

Industry: Biotechnology

CEO: Dr. Laxminarayan Bhat Ph.D.

Sector: Healthcare

Employees: 15

Address: 19925 Stevens Creek Boulevard, Cupertino, CA 95014

Phone: 408 501 8881

Last updated: 2024-12-31

Sensei Biotherapeutics, Inc.

Market Cap: Lowest

Employees: Lowest

Immuno Phage platform

Sensei Biotherapeutics, Inc. is a biopharmaceutical company focused on the discovery and development of immunotherapies for cancer, leveraging platforms such as Immuno Phage and Tumor Microenvironment Activated Biologics.

Tags: bacteriophage, biopharmaceutical, cancer treatment, immunotherapy, monoclonal antibodies

Website

About | About | Contact | About | About

Symbol: SNSE

Recent Price: $0.48

Industry: Biotechnology

CEO: Mr. John K. Celebi M.B.A.

Sector: Healthcare

Employees: 28

Address: 451 D Street, Rockville, MD 02210

Phone: 240 243 8000

Last updated: 2024-12-31

Spyre Therapeutics, Inc.

Market Cap: High

Employees: Lowest

antibody therapeutics

Spyre Therapeutics, Inc. is a biotechnology company focusing on antibody therapeutics for treating inflammatory bowel disease, using advanced engineering and precision medicine.

Tags: antibody therapeutics, biotechnology, inflammatory bowel disease, precision medicine

Website

About | Contact | Careers | About | About

Symbol: SYRE

Recent Price: $22.54

Industry: Biotechnology

CEO: Dr. Cameron Turtle DPHIL, Ph.D.

Sector: Healthcare

Employees: 50

Address: 221 Crescent Street, Waltham, MA 02453

Phone: 617 651 5940

Last updated: 2024-12-31

Agenus Inc.

Market Cap: Low

Employees: Medium

Retrocyte Display

Agenus Inc. is a clinical-stage immuno-oncology company that discovers and develops immuno-oncology products, offering antibody expression platforms, vaccine programs, and various monoclonal antibodies for cancer treatment.

Tags: antibody expression, cancer treatment, clinical trials, immuno-oncology, vaccine development

Website

Symbol: AGEN

Recent Price: $2.69

Industry: Biotechnology

CEO: Dr. Garo H. Armen Ph.D.

Sector: Healthcare

Employees: 389

Address: 3 Forbes Road, Lexington, MA 02421-7305

Phone: 781 674 4400

Last updated: 2024-12-31

Apollomics, Inc.

Market Cap: Lowest

Employees: Lowest

APL-101 (Vebreltinib), APL-102, APL-122

Apollomics, Inc. is a biotechnology company that discovers and develops oncology therapies to address unmet medical needs, focusing on treatments for non-small cell lung cancer, liver cancer, breast cancer, esophageal cancer, and brain tumors.

Tags: biotechnology, brain tumors, c-Met inhibitor, cancer therapy, non-small cell lung cancer, oncology, tyrosine kinase inhibitor

Website

Symbol: APLM

Recent Price: $10.13

Industry: Biotechnology

CEO: Dr. Guo-Liang Yu Ph.D.

Sector: Healthcare

Employees: 45

Address: 989 East Hillsdale Blvd, Foster City, CA 94404

Phone: 650 209 4055

Last updated: 2024-12-31

Checkpoint Therapeutics, Inc.

Market Cap: Low

Employees: Lowest

Cosibelimab

Checkpoint Therapeutics, Inc. is a clinical-stage immunotherapy and targeted oncology company focused on acquiring, developing, and commercializing novel treatments for solid tumor cancers. Their lead product candidates include Cosibelimab, a fully-human monoclonal antibody, and other treatments for various cancer targets.

Tags: Antibody, Cancer Treatment, Cosibelimab, EGFR Inhibitor, Immunotherapy, Oncology

Website

Contact | About | About

Symbol: CKPT

Recent Price: $3.35

Industry: Biotechnology

CEO: Mr. James F. Oliviero III, C.F.A.

Sector: Healthcare

Employees: 23

Address: 95 Sawyer Road, Waltham, MA 02453

Phone: 781 652 4500

Last updated: 2024-12-31

Cue Biopharma, Inc.

Market Cap: Low

Employees: Lowest

CUE-101

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company developing biologic drugs to modulate the human immune system for treating cancers, chronic infectious diseases, and autoimmune disorders.

Tags: autoimmune disorders, biopharmaceutical, cancer, chronic diseases, immune system

Website

Symbol: CUE

Recent Price: $1.02

Industry: Biotechnology

CEO: Mr. Daniel R. Passeri J.D., M.Sc.

Sector: Healthcare

Employees: 53

Address: 21 Erie Street, Cambridge, MA 02139

Phone: 617 949 2680

Leadership

Dan Passeri, Chief Executive Officer
Anish Suri, President and Chief Scientific Officer
Lucinda Warren, Chief Business Officer
Matteo Levisetti, Chief Medical Officer
Kerri-Ann Millar, Chief Financial Officer
Colin Sandercock, Senior Vice President and General Counsel
Frank Morich, M.D., Ph.D., Chairman of the Board
Dan Passeri, M.Sc., J.D., Chief Executive Officer
Peter Kiener, D.Phil.,
Fred Driscoll,
Patrick Verheyen,
Pamela D. Garzone, Ph.D.,

Last updated: 2024-12-31

Greenwich LifeSciences, Inc.

Market Cap: Low

Employees: Lowest

GP2

Greenwich Life Sciences, Inc. is a clinical stage biopharmaceutical company focusing on developing novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers, with a lead product candidate GP2, which aims to prevent breast cancer recurrences.

Tags: GP2, HER2/neu, biopharmaceutical, breast cancer, cancer immunotherapy, clinical trial

Website

Symbol: GLSI

Recent Price: $10.91

Industry: Biotechnology

CEO: Mr. Snehal S. Patel

Sector: Healthcare

Employees: 3

Address: Building 14, Stafford, TX 77477

Phone: 832 819 3232

Last updated: 2024-12-31

Immunome, Inc.

Market Cap: Medium

Employees: Low

IMM-ONC-01, IMM-BCP-01

Immunome, Inc. is a biopharmaceutical company focused on developing antibody therapeutics for oncology and infectious diseases, offering innovative solutions such as IMM-ONC-01 for cancer and IMM-BCP-01 for COVID-19 treatment.

Tags: antibody therapeutics, biopharmaceutical, infectious disease, oncology

Website

Contact | Careers | Jobs

Symbol: IMNM

Recent Price: $10.28

Industry: Biotechnology

CEO: Dr. Clay B. Siegall Ph.D.

Sector: Healthcare

Employees: 78

Address: 665 Stockton Drive, Exton, PA 19341

Phone: 610 321 3700

Last updated: 2024-12-31

Imunon, Inc.

Market Cap: Lowest

Employees: Lowest

GEN-1, Thermo Dox

Imunon, Inc. is a clinical stage biotechnology company specializing in the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies, focusing on products such as GEN-1 for ovarian cancer and Thermo Dox for various cancer indications.

Tags: Biotechnology, Cancer Treatment, DNA Therapies, Immunotherapy, Vaccines

Website

Symbol: IMNN

Recent Price: $0.82

Industry: Biotechnology

CEO: Dr. Stacy R. Lindborg Ph.D.

Sector: Healthcare

Employees: 33

Address: 997 Lenox Drive, Lawrenceville, NJ 08648

Phone: 609 896 9100

Leadership

Stacy R. Lindborg, PhD, President, Chief Executive Officer, and Board Director
David Gaiero, Chief Financial Officer
Khursheed Anwer, PhD, MBA, Executive Vice President and Chief Science Officer
Kristin Longobardi, MBA, Senior Vice President, Strategic Operations
Susan Eylward, General Counsel and Corporate Secretary
Michael H. Tardugno,
Frederick J. Fritz,
Donald Braun, PhD,
Christine Pellizzari, JD,
James E. Dentzer,

Last updated: 2024-12-31

Immuneering Corporation

Market Cap: Lowest

Employees: Low

IMM-1-104 and IMM-6-415

Immuneering Corporation is a biopharmaceutical company focused on developing oncology and neuroscience product candidates, with key products like IMM-1-104 for cancer treatment and IMM-6-415 for solid tumors.

Tags: biopharmaceutical, cancer treatment, drug development, neuroscience, oncology

Website

About | Contact | About | About

Symbol: IMRX

Recent Price: $2.25

Industry: Biotechnology

CEO: Dr. Benjamin J. Zeskind M.B.A., Ph.D.

Sector: Healthcare

Employees: 66

Address: 245 Main Street, Cambridge, MA 02142

Phone: 617 500 8080

Last updated: 2024-12-31

Immunic, Inc.

Market Cap: Low

Employees: Low

IMU-838

Immunic, Inc. develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, in Phase 2 clinical trials for multiple conditions, including relapsing-remitting multiple sclerosis.

Tags: autoimmune diseases, biopharmaceutical, chronic inflammatory diseases, clinical trials, immunology, therapies

Website

Symbol: IMUX

Recent Price: $1.03

Industry: Biotechnology

CEO: Dr. Daniel Vitt Ph.D.

Sector: Healthcare

Employees: 85

Address: 1200 Avenue of the Americas, New York, NY 10036

Phone: 332 255 9818

Last updated: 2024-12-31

NexImmune, Inc.

Market Cap: Lowest

Employees: Lowest

Artificial Immune Modulation

Nex Immune, Inc., a clinical-stage biotechnology company, develops therapies for cancer and immune-mediated diseases using its Artificial Immune Modulation platform. The company is advancing cell therapy candidates including NEXI-001, NEXI-002, and NEXI-003.

Tags: T cell immunotherapies, biotechnology, cancer, cell therapy, immune-mediated diseases, nanoparticle technology

Website

Symbol: NEXI

Recent Price: $0.15

Industry: Biotechnology

CEO: Mr. John Trainer M.B.A.

Sector: Healthcare

Employees: 6

Address: 9119 Gaither Road, Gaithersburg, MD 20877

Phone: 301 825 9810

Leadership

Kristi Jones, Chief Executive Officer
Mathias Oelke, Ph.D., Chief Scientific Officer
Daniel Bednarik Ph.D., Senior Vice President, Molecular Engineering & Protein Design
Jack Ragheb, Senior Vice President, Translational Science
Tonya Catterton, Vice President, Quality & Compliance
Tim Stover, Vice President, Corporate Controller
Karen Haslbeck, Head, Human Resources
Matt Schiller, Head, Business Development

Last updated: 2024-12-31

Repligen Corporation

Market Cap: Highest

Employees: High

bioprocessing technologies and systems

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing worldwide, offering products like Protein A ligands, chromatography columns, ELISA test kits, and filtration products.

Tags: ELISA test kits, Protein A ligands, biologics purification, bioprocessing, chromatography, filtration systems

Website

Symbol: RGEN

Recent Price: $143.81

Industry: Medical - Instruments & Supplies

CEO: Mr. Olivier Loeillot

Sector: Healthcare

Employees: 1783

Address: Building 1, Waltham, MA 02453

Phone: 781 250 0111

Leadership

Mark A. Gambino, President and CEO
Pradeep K. Gohil, Chief Financial Officer
Matthew B. Wrobel, Chief Technology Officer
Claudia A. Grunewald, Director of Quality Assurance
Mickey R. Perry, Chief Operating Officer
Paul C. Miller, General Counsel and Secretary
James J. O'Brien, Chairman of the Board
Diane Williams, Board Member
Charles A. Jamieson, Board Member
Rebecca D. Faulkner, Board Member

Last updated: 2024-12-31

Revolution Medicines, Inc.

Market Cap: Highest

Employees: Medium

RMC-4630

Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing therapies targeting frontier targets in RAS-addicted cancers.

Tags: RAS-addicted cancers, cancer therapy, clinical trials, oncology, precision medicine

Website

Symbol: RVMD

Recent Price: $43.17

Industry: Biotechnology

CEO: Dr. Mark A. Goldsmith Ph.D.

Sector: Healthcare

Employees: 378

Address: 700 Saginaw Drive, Redwood City, CA 94063

Phone: 650 481 6801

Last updated: 2024-12-31

Abeona Therapeutics Inc.

Market Cap: Low

Employees: Low

EB-101

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa.

Tags: EB-101, biopharmaceutical, cell therapy, clinical trials, gene therapy, rare genetic diseases

Website

About | About | About

Symbol: ABEO

Recent Price: $5.61

Industry: Biotechnology

CEO: Dr. Vishwas Seshadri M.B.A., Ph.D.

Sector: Healthcare

Employees: 84

Address: 1330 Avenue of the Americas, New York, NY 10019

Phone: 646 813 4701

Last updated: 2024-12-31

🔥🐔 BizChicken 🐔🔥

Companies Similar to Replimune Group, Inc.

Sign Up Today!

ImmunityBio, Inc.

Lyell Immunopharma, Inc.

Leadership

INmune Bio, Inc.

Replimune Group, Inc.

Reviva Pharmaceuticals Holdings, Inc.

Sensei Biotherapeutics, Inc.

Spyre Therapeutics, Inc.

Agenus Inc.

Apollomics, Inc.

Checkpoint Therapeutics, Inc.

Cue Biopharma, Inc.

Leadership

Greenwich LifeSciences, Inc.

Immunome, Inc.

Imunon, Inc.

Leadership

Immuneering Corporation

Immunic, Inc.

NexImmune, Inc.

Leadership

Repligen Corporation

Leadership

Revolution Medicines, Inc.

Abeona Therapeutics Inc.

Choose Your Sign-In Method